 |
|
|
 |
|
Strategy Enhancing strategic decision-making A company is having difficulty evaluating market opportunities in a given therapeutic area. It asks S&BD International to thoroughly analyze the therapeutic area and to come up with strategic recommendations whether or not entering this therapeutic area would suit the company’s mid- and long term goals. Analyzing product portfolio A biotech company wants to attract additional capital and wants to approach venture capitalists. For preparing a convincing company presentation the company calls on S&BD International’s expertise. S&BD International analyzes the portfolio, evaluates its risk structure and valuates it. “Next Milestone Completed” analyses which complete the picture are carried out. Finally, S&BD International composes a professional and very convincing company presentation. Rationalizing prioritization of R&D projects In order to spend the limited R&D budget more rationally, a company is looking for a technique which enhances prioritization of the R&D projects. S&BD International is engaged and suggests the real options valuation technique. First, target product profiles are defined followed by the creation of decision tree models which establish the milestones in development and their associated risks. Then market models are prepared which together with the decision tree models render so-called “expected” or “augmented” NPVs. Eventually the models and calculations provide the company with clear guidance on the prioritization of their R&D projects. Devising a commercialization strategy A company has a compound in Phase III development and limited marketing staff. The company asks S&BD International to devise a commercialization strategy for the compound. S&BD International analyzes the market, determines the compound’s competitive edge over current and future competitors and proposes a strategy which best fits the compound, the market and the company. Market introduction: forecast model A company has a compound in late stage development and needs a comprehensive forecast model. The company engages S&BD International for preparing the model. S&BD builds a robust epidemiology based model which allows for sensitivity analysis and Monte Carlo simulation. Additional, S&BD International recommends on the market research that needs to be conducted for validating the input parameters. Bridging a revenue gap A company faces a serious revenue gap in the next four years due to the combination of a patent expiry and the follow up compound being killed in late stage development. S&BD International develops a strategy for bridging the gap until the company’s own pipeline will deliver the next growth opportunity. The strategy is built on life cycle management elements, co-promotion activities and licensing opportunities. |
|
 |
|
| All contents © copyright
2006 S&BD International. All rights reserved.
Contact e-mail: info@snbdinternational.com |
|